COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 10: Articles 91-100  | Next

Emulating the gingival-tooth interface during bacterial, fungal, and viral infection in a microphysiological model of the human oral cavity
Younesi, M., Fattahi, P., Ren, Z., Lee, W. D., Cherry, S., Koo, H., Huh, D. D.
10.64898/2026.06.11.731421 — Posted: 2026-06-12
Molecular and ecological determinants of effective reassortment in orthohantaviruses
Rivero, R., Simons, D., Damodaran, L., Karegi, I., Gurev, S., Becker, D. J., Warren, D. L., Mueller, N. F., Rasmussen, D. A., Seifert, S. N.
10.64898/2026.06.10.731004 — Posted: 2026-06-12
Hantavirus Disease in Uruguay: Trends and Mortality Before and During the COVID-19 Pandemic.
criscuolo, z., Blanco, L., Ferrara, F., Ciaccio, K., Gomez Carassale, L., Gonzalez Reyes, M., Machado Rivero, B., Sosa Dias, F., Facal Castro, J. A.
10.64898/2026.06.10.26355375 — Posted: 2026-06-11
Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells
Matsui, Y., Suryawanshi, R. K., Montano, M., Taha, T. Y., Khalid, M., Sun, L., Khanna, K., Tang, J., Zhou, Y., Kaake, R. M., Fang, X., Maishan, M., Matthay, M. A., Krogan, N. J., Ott, M.
10.64898/2026.06.10.731427 — Posted: 2026-06-11
Cross-protection against Bundibugyo by Ebola and Sudan vaccines
Kelchtermans, L., Lemmens, V., Neyts, J., Alpizar, Y. A., Dallmeier, K.
10.64898/2026.06.10.731377 — Posted: 2026-06-11
Mechanisms of viral budding through cellular membranes
Zhang, S., Li, S., Coronado-Ipina, M. A., Comas-Garcia, M., Gopinathan, A., Schoot, P. v. d., Zandi, R.
10.64898/2026.06.10.731270 — Posted: 2026-06-11
A Clinical Predictor of Lung Molecular Endotype Identifies Heterogeneity in Corticosteroid Response in Severe COVID-19: an Emulated Target Trial
Sines, B., Hagan, R., Jiang, X., Pavlechko, E., McClain, S., Hunt, X., Florou-Moreno, J., Acquadro, J., Risa, G., Valsaraj, V., Schisler, J., Wolfgang, M. C.
10.64898/2026.06.08.26355201 — Posted: 2026-06-10
A risk-of-contagion index using a Bayesian based model for the COVID-19 epidemic in Mexico
Corona-Moreno, R., Acuna-Zegarra, M. A., Santana-Cibrian, M., Velasco-Hernandez, J. X.
10.64898/2026.06.09.26355274 — Posted: 2026-06-10
Estimating COVID-19 Cumulative Incidence from Seroprevalence Surveys accounting for Time-Varying Seroreversion: A Fully Bayesian Methodology
Owusu-Boaitey, N., Meyer, M. J., Herrera-Esposito, D., Bottcher, L., Lukz, M., Cook, S., Stoto, M. A., Kraemer, J. D.
10.64898/2026.06.09.26355264 — Posted: 2026-06-10
Sennoside A and Ceftazidime Inhibit Nucleocapsid RNA BindingAcross SARS-CoV-2, SARS-CoV, and MERS-CoV
Singh, S., Gupta, G. D.
10.64898/2026.06.09.731089 — Posted: 2026-06-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).